CLINICAL_TRIALS
trial_result
· 2016-10-27
Clinical Trial Update: A Long-term Safety Study of ALKS 9072 (Also Known as ALKS 9070) [Phase 3]
Summary
A long-term safety Phase 3 study of ALKS 9072/ALKS 9070 in schizophrenia has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Alkermes, Inc. | Conditions: Schizophrenia | Phase 3 | Status: COMPLETED | Results posted: 2016-10-27